> (Немає відомостей про примірники) Шифр: N3/2003/18/Suppl.5 Журнал 2003р. Vol. 18 Suppl.5 Kveder, R. Foreword / R. Kveder. - P.v1 Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials. - P.v2-v4 Сlinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)- associated glomerulonephritis in elderly patients. - P.v5-v7 : табл. Balla, J. Haem, haem oxygenase and ferritin in vascular endothelial cell injury / J. Balla, G.M. Vercellotti, K. Nath. - P.v8-v12. - Bibliogr.: 47 ref. : граф. Deliyska, B. The efficacy of an individual treatment schedule in patients with vasculitis / B. Deliyska, V. Shurliev. - P.v13-v15 Wiecek, A. Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications / A. Wiecek, J. Chudek, F. Kokot. - P.v16-v20 : граф. Sonkodi, S. Treatment of diabetic nephropathy with angiotensin II blockers / S. Sonkodi, A. Mogyorosi. - P.v21-v23 Genetics of diabetic nephropathy. - P.v24-v25 Polenakovic, M. H. The incidence of biopsy-proven primary glomerulonephritis in the Republic of Macedonia - long-term follow-up / M.H. Polenakovic, L. Grcevska, S. Dzikova. - P.v26-v27 : граф. Ljutic, D. The role of arterial hypertension in the progression of non-diabetic glomerular diseases / D. Ljutic, P. Kes. - P.v28-v30 Kiperova, B. The treatment of glomerular disease - a compromise between the standard and the individual approach / B. Kiperova. - P.v31-v33 Kveder, R. Therapy-resistant focal and segmental glomerulosclerosis / R. Kveder. - P.v34-v37 Rysava, R. Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients / R. Rysava, M. Merta, V. Tesar. - P.v38-v40 : табл. Opatrny, K. Clinical importance of biocompatibility and its effect on haemodialysis treatment / K. Opatrny. - P.v41-v44 Pavlovic, D. Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist ? / D. Pavlovic, H.T. Brzac. - P.v45-v46 : фото Cizman, B. Hyperphosphataemia and treatment with sevelamer in haemodialysis patients / B. Cizman. - P.v47-v49 Malovrh, M. Approach to patients with end-stage renal disease who need an arteriovenous fistula / M. Malovrh. - P.v50-v52 Buturovic-Ponikvar, J. Renal replacement therapy in Slovenia : annual report 2001 / J. Buturovic-Ponikvar. - P.v53-v55 : табл. Сurrent applications of plasmapheresis in clinical toxicology. - P.v56-v58 : табл. Sulowicz, W. LDL-apheresis and immunoadsorption: novel methods in the treatment of renal diseases refractory to conventional therapy / W. Sulowicz, T. Stompor. - P.v59-v62 Ponikvar, R. Blood purification in the intensive care unit / R. Ponikvar. - P.v63-v67. - Bibliogr.: 22 ref. Co-morbidity and kidney graft failure-two main causes of malnutrition in kidney transplant patients. - P.v68-v70 : табл. Obesity and hyperhomocysteinaemia after kidney transplantation. - P.v71-v73 : табл. Buturovic-Ponikvar, J. Renal transplant artery stenosis / J. Buturovic-Ponikvar. - P.v74-v77 Немає відомостей про примірники |